You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

FULVICIN P Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Fulvicin P, and when can generic versions of Fulvicin P launch?

Fulvicin P is a drug marketed by Chartwell Rx and is included in one NDA.

The generic ingredient in FULVICIN P is griseofulvin, ultramicrosize. There is one drug master file entry for this compound. Five suppliers are listed for this compound. Additional details are available on the griseofulvin, ultramicrosize profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Fulvicin P

A generic version of FULVICIN P was approved as griseofulvin, ultramicrosize by MOUNTAIN on January 9th, 2014.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for FULVICIN P?
  • What are the global sales for FULVICIN P?
  • What is Average Wholesale Price for FULVICIN P?
Summary for FULVICIN P
US Patents:0
Applicants:1
NDAs:1
DailyMed Link:FULVICIN P at DailyMed
Drug patent expirations by year for FULVICIN P

US Patents and Regulatory Information for FULVICIN P

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Rx FULVICIN P/G griseofulvin, ultramicrosize TABLET;ORAL 061996-001 Approved Prior to Jan 1, 1982 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chartwell Rx FULVICIN P/G 330 griseofulvin, ultramicrosize TABLET;ORAL 061996-004 Apr 6, 1982 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chartwell Rx FULVICIN P/G griseofulvin, ultramicrosize TABLET;ORAL 061996-002 Approved Prior to Jan 1, 1982 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chartwell Rx FULVICIN P/G 165 griseofulvin, ultramicrosize TABLET;ORAL 061996-003 Apr 6, 1982 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.